Purpose The primary purpose of this systematic review is to synthesize the evidence
regarding risk factors associated with nonadherence to prescribed glucose-lowering agents …

BACKGROUND: Significant disparities exist in cardiovascular outcomes based on
race/ethnicity and gender. Rates of evidence-based medication use and long-term …

Objective Despite evidence indicating therapeutic benefit for adhering to a prescribed
regimen, many patients do not take their medications as prescribed. Non-adherence often …

Purpose Systemic exposure to mercaptopurine (MP) is critical for durable remissions in
children with acute lymphoblastic leukemia (ALL). Nonadherence to oral MP could increase …

Background Poor medication refill adherence contributes to poor cardiometabolic control
and diabetes outcomes. Studies linking communication between patients and health care …

Similar to non-Hispanic Blacks, Hispanics/Latinos experience a range of psychosocial and
physical health challenges, including high rates of poverty, neighborhood segregation …

OBJECTIVE To assess the association of compliance with treatment (medication and clinic
appointments) and all-cause mortality in people with insulin-treated type 2 diabetes …

Durable remissions in children with acute lymphoblastic leukemia (ALL) require a 2-year
maintenance phase that includes daily oral 6-mercaptopurine (6MP). Adherence to oral 6MP …

Background: Medication nonadherence is known to worsen glycemic control. Few studies
have examined this relationship over several years. Objective: The aim of this study was to …

Low drug adherence is a major obstacle to the benefits of pharmacotherapies and it is
therefore important to identify factors associated with discontinuing or being poorly adherent …